Nature Reviews Cancer 17, 79β92 (2017)
In this article a source of grant funding for one of the authors was omitted from the Acknowledgements section. The online version of the article has been corrected to include: βThe work of R.D. was supported by the Grant for Oncology Innovation under the project 'Next generation of clinical trials with matched targeted therapies in colorectal cancer'β.
Additional information
The online version of the original article can be found at 10.1038/nrc.2016.126
Rights and permissions
About this article
Cite this article
Dienstmann, R., Vermeulen, L., Guinney, J. et al. Erratum: Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat Rev Cancer 17, 268 (2017). https://doi.org/10.1038/nrc.2017.24
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc.2017.24
This article is cited by
-
Mechanistic insights into WntβΞ²-catenin pathway activation and signal transduction
Nature Reviews Molecular Cell Biology (2025)
-
Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable prognosis
British Journal of Cancer (2024)
-
Tumor suppressor ACER1 correlates with prognosis and Immune Infiltration in head and neck squamous cell carcinoma
Scientific Reports (2024)
-
CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p
Journal of Cancer Research and Clinical Oncology (2024)
-
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors
Journal of Experimental & Clinical Cancer Research (2024)
